Key Highlights

  • Clearmind Medicine entered a definitive agreement to acquire a 51% stake in Charging Robotics.
  • Charging Robotics is an EV wireless charging company.
  • Terms include $2.5 million plus a $1.5 million Loan at 4% interest.
  • The move marks a Diversification away from Clearmind's psychedelic therapeutics focus, shortly after initiating Phase 2a testing of CMND-100 in alcohol use disorder.

Clearmind Medicine Inc. (NASDAQ: CMND) entered a definitive agreement to acquire a 51% stake in EV wireless charging company Charging Robotics for $2.5 million plus a $1.5 million 4% loan.

What Happened

The transaction marks a non-core diversification move away from Clearmind's psychedelic therapeutics focus, coming shortly after the company initiated Phase 2a testing of CMND-100 in alcohol use disorder.

Market Reaction

The disclosed information does not include stock price or trading data for Clearmind Medicine following the Acquisition announcement.

Outlook

Completion of the Charging Robotics acquisition, alongside continued progress in the Phase 2a CMND-100 trial for alcohol use disorder, represent the next relevant developments for Clearmind Medicine across its now-diversified business.